ArticleBlood advances2020

Clinical MDR1 inhibitors enhance Smac-mimetic bioavailability to kill murine LSCs and improve survival in AML models.

Emma Morrish et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.